IL2 and neoplasm: In a study wherein mice were challenged with B16F10 melanoma, treatment by adoptive transfer of transgenic tumor-specific CD8+ T cells, combined administration of IL-21 and IL-2 and vaccination resulted in higher absolute numbers of circulating tumor-specific T cells and improved tumor-free survival compared to therapy with IL-2 or IL-21 alone (203).